The retailer saw
TTM sales of $ 35 billion, and even with a $ 2.7 billion market value (based on the real estate portfolio), the company would still only trade at 0.08 x sales.
There was an immediate impact on sales of $ 67 million versus the company's current
TTM sales is $ 1.56 billion.
Not exact matches
In terms of valuation, Valeant Pharmaceuticals stock currently trades at
TTM price to
sales value of 0.58 x and price to book value of 1.40 x.
Free Cash Flow Yield (
ttm): 5.2 % (11/17 points) EV to EBIT (
ttm): 13.4 EV to EBITDA (
ttm): 15.3 (8/17 points) Price to
Sales Ratio (
ttm): 3.4 Price to Book Value (
ttm): 3.2 Price to Earnings Ratio (P / E)(
ttm): n / a PE 10: 19
Free Cash Flow Yield (
ttm): 2.4 % (6/17 points) EV to EBIT (
ttm): 24.6 EV to EBITDA (
ttm): 21.8 (0/17) Price to
Sales Ratio (
ttm): 3.1 Price to Book Value (
ttm): 11.1 Price to Earnings Ratio (P / E)(
ttm): 63 PE 10: 46
Free Cash Flow Yield (
ttm): 3.9 % (9/17 points) EV to EBIT (
ttm): 18.7 EV to EBITDA (
ttm): 16.5 (5/17 points) Price to
Sales Ratio (
ttm): 4.1 Price to Book Value (
ttm): n / a Price to Earnings Ratio (P / E)(
ttm): 31 PE 10: 32
Free Cash Flow Yield (
ttm): 5.0 % (11/17 points) EV to EBIT (
ttm): 19.4 (3/9 points) EV to EBITDA (
ttm): 15.5 (8/17 points) Price to
Sales Ratio (
ttm): 4.5 Price to Book Value (
ttm): 5.7 Price to Earnings Ratio (P / E)(
ttm): 329 PE 10: 28
Those who insist on using irrelevant metrics like
TTM PE or forward operating PE to value stocks have been deluded by the biggest
sales machine on earth — the Wall Street Complex.
Free Cash Flow Yield (
ttm): 3.6 % (9/17 points) EV to EBIT (
ttm): 18.6 EV to EBITDA (
ttm): 14.8 (8/17 points) Price to
Sales Ratio (
ttm): 2.9 Price to Book Value (
ttm): 5.5 Price to Earnings Ratio (P / E)(
ttm): 29 PE 10: 25